TY  - JOUR

T1  - APPENDIX D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy

JO  - CONTINUUM: Lifelong Learning in Neurology

PY  - 2007/08/01

AU  - &NA;

ED  - 

DO  - DOI: 10.1212/01.con.0000284530.12778.9b

PB  - Ovid Technologies (Wolters Kluwer Health)

VL  - 13

SP  - 212

EP  - 224

Y2  - 2024/12/22

ER  -